Depression and Aspartate aminotransferase increased
Aspartate aminotransferase increased is found among people with Depression, especially for people who are female, 60+ old.
The study analyzes which people have Aspartate aminotransferase increased with Depression. It is created by eHealthMe based on reports of 1,853 people who have Depression from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,853 people who have Depression and Aspartate Aminotransferase Increased are studied.
What is Depression?
Depression is found to be associated with 4,177 drugs and 4,011 conditions by eHealthMe.
What is Aspartate aminotransferase increased?
Aspartate aminotransferase increased is found to be associated with 3,120 drugs and 3,096 conditions by eHealthMe.
Number of Aspartate aminotransferase increased in Depression reports submitted per year:
Gender of people who have Depression and experienced Aspartate aminotransferase increased *:
Age of people who have Depression and experienced Aspartate aminotransferase increased *:
Common co-existing conditions for these people *:
Common drugs taken by these people *:
Common symptoms for these people *:
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Aspartate aminotransferase increased?Check whether Aspartate aminotransferase increased is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
Treatments, associated drugs and conditions:
- Depression (598,782 reports)
- Aspartate aminotransferase increased (74,221 reports)
COVID vaccines that are related to Aspartate aminotransferase increased:
- Aspartate aminotransferase increased in Moderna COVID Vaccine
- Aspartate aminotransferase increased in Pfizer BioNTech Covid Vaccine
- Aspartate aminotransferase increased in Johnson and Johnson Covid Vaccine
Common drugs associated with Aspartate aminotransferase increased:
- Methotrexate: 3,366 reports
- Prednisone: 3,219 reports
- Aspirin: 2,764 reports
- Tracleer: 2,583 reports
- Lasix: 2,348 reports
- Lipitor: 2,163 reports
- Prednisolone: 2,159 reports
- Furosemide: 2,157 reports
- Omeprazole: 1,937 reports
- Enbrel: 1,802 reports
All the drugs that are associated with Aspartate aminotransferase increased:
- Aspartate aminotransferase increased (3,120 drugs)
Common conditions associated with Aspartate aminotransferase increased:
- High blood pressure: 3,411 reports
- Rheumatoid arthritis: 3,130 reports
- Multiple sclerosis: 2,489 reports
- Depression: 1,853 reports
- Pain: 1,627 reports
- High blood cholesterol: 1,590 reports
- Primary pulmonary hypertension: 1,503 reports
All the conditions that are associated with Aspartate aminotransferase increased:
- Aspartate aminotransferase increased (3,096 conditions)
How the study uses the data?
The study is based on Aspartate aminotransferase increased and Depression, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ampyra and Headache - 19 seconds ago
- Nucynta Er and High Blood Pressure - 28 seconds ago
- Cefdinir and Videx drug interaction - 50 seconds ago
- Celebrex and Stent - 54 seconds ago
- Qvar and Enlarged Prostate - 59 seconds ago
- Warfarin Sodium and Unisom drug interaction - a minute ago
- Zoledronic and Creon drug interaction - a minute ago
- Gentamicin and Hepatic Encephalopathy - a minute ago
- Actonel With Calcium and Oxygen Saturation Decreased - a minute ago
- Prochlorperazine Edisylate and Dyspepsia Aggravated - a minute ago